ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.380
+0.200 (16.95%)
At close: Nov 7, 2025, 4:00 PM EST
1.260
-0.120 (-8.70%)
After-hours: Nov 7, 2025, 7:25 PM EST
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $73.9 million as of November 7, 2025. Its market cap has decreased by -15.48% in one year.
Market Cap
73.90M
Enterprise Value
10.77M
1-Year Change
-15.48%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $73.90M, a decrease of -93.00%. That is a compound annual growth rate of -39.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 73.90M | -16.10% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |